Jianqin Lu

Education: 

• Postdoc, Nanomedicine/Tumor Immunology, University of California, Los Angeles, 2019
• Postdoc, Nanomedicine, The University of Chicago, Chicago, 2015
• PhD, Pharmaceutics, University of Pittsburgh, Pittsburgh, 2014
• BS, Pharmacy, Hunan University of Chinese Medicine, Changsha, China, 2010

Jianqin Lu, BPharm, PhD, is an Assistant Professor of Pharmaceutical Sciences in Pharmaceutics and Pharmacokinetics, at the University of Arizona College of Pharmacy. The overarching goal of the Lu lab is to apply synthetic chemistry, nanoparticle engineering, and tumor immunology to develop efficacious and preventative  nanotherapeutics to address the pressing unmet needs in current cancer therapy and environmental exposure-induced toxicity. The Lu Lab's expertise in Pharmaceutics, Drug Delivery, Nanomedicine and Tumor Immunology paves the way to develop transformative and clinically translatable nanoimmunotherapeutics for combatting cancers and preventing environmental disease. Dr. Lu was the recipient of the Norman R. and Priscilla A. Farnsworth Award at University of Pittsburgh, and USHHS Ruth L. Kirschstein Institutional National Research Service Award in Tumor Immunology among others.

Environmental research interests - Drug Delivery, Nanomedicine, Pharmaceutics and Pharmacokinetics, Nano-ImmunoEngineering, Cancer Immunotherapy and Chemotherapy, Targeted lung therapy, COVID-19 nanotherapeutics